Clinical Trials · NCT00423475
Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- UNICANCER
- Enrollment
- 743
- Start date
- Oct 2006
- Locations
- 31 sites, France
- Primary endpoint
- Progression-free (biological and/or clinical) survival